Advertisement

Topics

Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results

06:50 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
-- Bendeka® market share grew to 92% -- -- Bendeka reached $500 million in cumulative sales in Q1 2017, triggering $25 million milestone -- -- 2016 Revenue grew 186% to $189.5 million -- -- Q4 ...

Other Sources for this Article

Investor Relations for Eagle Pharmaceuticals, Inc.:
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
lwilson@insitecony.com

NEXT ARTICLE

More From BioPortfolio on "Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...